Longitudinal Changes in Vascular Risk Markers and Mortality Rates among a Latino Population with Hypertension

Insights

Vascular markers like pulse-wave velocity and carotid intima-media thickness (CIMT) predict cardiovascular disease risk and mortality in minority populations, outperforming inflammatory markers.

Area of Science:

  • Cardiovascular Disease Epidemiology
  • Vascular Biology
  • Biomarker Research

Background:

  • Traditional cardiovascular disease risk factors may not fully capture risk in minority populations.
  • Vascular markers like pulse-wave velocity and carotid intima-media thickness (CIMT) show promise for improved risk prediction.
  • Characterization of these markers in diverse populations is limited.

Purpose of the Study:

  • To evaluate vascular markers (arterial pulse-wave velocity, CIMT) and inflammatory biomarkers for predicting cardiovascular disease and mortality in a hypertensive minority cohort.
  • To assess the longitudinal changes and correlations of these markers over time.
  • To determine if vascular markers offer superior prediction compared to inflammatory markers.

Main Methods:

  • Prospective, longitudinal cohort study in hypertensive patients at an urban safety-net hospital.
  • Evaluation of inflammatory biomarkers, pulse-wave velocity, and CIMT at baseline, 1 year, and 2 years.
  • Generalized linear mixed-effects models for CIMT associations; administrative and National Death Index data for mortality.

Main Results:

  • Pulse-wave velocity and CIMT regressed over time and were highly correlated (P <0.001).
  • Only pulse-wave velocity (P=0.002) and total cholesterol (P=0.03) associated with CIMT in time-varying analysis.
  • Higher baseline CIMT and pulse-wave velocity correlated with increased mortality (P <0.01); no inflammatory marker showed significant correlation with CIMT changes or death.

Conclusions:

  • Arterial stiffness and preclinical carotid atherosclerosis are significant predictors of mortality in this minority population.
  • Vascular markers, specifically pulse-wave velocity and CIMT, may serve as valuable risk-stratification tools.
  • Inflammatory biomarkers did not demonstrate significant utility in predicting longitudinal CIMT changes or mortality in this cohort.

Related Concept Videos

Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
649
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.6K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
709
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.7K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
824